The Operating System
for Clinical Development
Aurora Analytica™ transforms compressed 7–10 day proposal cycles into AI-assisted decision workflows — enabling CROs to design stronger bids, validate strategy, and win more trials.
Clinical trials are won before they begin —
but most teams are flying blind.
Inside the typical 10-day RFP window, feasibility and strategy get squeezed into a fraction of the time — and the consequences are enormous.
Compressed Timelines
Only 1–2 days allocated to feasibility and strategy — forcing teams to rely on instinct over intelligence.
Fragmented Data
Multiple registries, internal databases, and trial files reconciled manually in spreadsheets under deadline pressure.
Massive Execution Risk
A single missed Tier 1 award represents enormous lost contract value — and faulty assumptions compound post-award.
One Platform. Complete Intelligence.
Four core decision engines and eight expanded modules — designed to transform every stage of clinical trial strategy.
The Full Aurora Suite™
Starlite-AI™
The Autonomous Intelligence Layer
The intelligence layer that thinks for itself. Starlite-AI™ autonomously orchestrates the entire Aurora Suite™ — ingesting RFPs, running multi-source feasibility analysis, generating country strategies, and delivering proposal-ready outputs. No manual steps. No bottlenecks.
Search 550K+ Trials
Search any disease area to see live trial intelligence from the Trial Core™ database.
Proof That Changes Minds
Real results from real deployments. Aurora Analytica™ is measured by the outcomes it delivers.
10/10
Client Satisfaction
Global CRO data intelligence teams rated Aurora 10/10 for overall experience and likelihood to recommend.
2 Days
RFP to Strategy
Aurora compresses the typical 7–10 day feasibility cycle into 48 hours of structured, AI-assisted strategy.
ESMO
Published
AI-driven feasibility methodology peer-reviewed and presented at one of the world's leading oncology conferences.
550K+
Trial Records
The Trial Core™ database aggregates over 550,000 trial records from 7+ global directories — the world's most comprehensive clinical intelligence foundation.
EIC
Accelerator Stage 1
Selected by the European Innovation Council — one of Europe's most competitive deep-tech funding programmes.
8/10
Time & Cost Saving
CRO case study: 8/10 time savings, 9/10 cost savings, 8/10 accuracy — transforming pre-award workflows.
What Our Clients Say
Extremely likely to recommend · Rated by global CRO data intelligence teams
10 / 10
Net Promoter Score
Global Feasibility Director
Global CRO
Read testimonial →
Evaluator
European Innovation Council (EIC)
Read testimonial →
“
Associate Director, Data Intelligence
Global CRO
Past CEO
CRO (Nordics)
Read testimonial →
Global Feasibility Director
Global CRO
Read testimonial →
“
Associate Director, Data Intelligence
Global CRO
Evaluator
European Innovation Council (EIC)
Read testimonial →
Past CEO
CRO (Nordics)
Read testimonial →
The Aurora Workflow
Four integrated steps that take you from raw RFP to proposal-ready strategy — powered by the full Aurora Suite™.
Foundation Intelligence
Start with Trial Core™ to access 550K+ trial records, enrolment benchmarks, and investigator intelligence — building the factual foundation for every strategic decision.
→ Validated site list readyCountry & Site Strategy
Geo Matrix™ converts your feasibility inputs into ranked country strategies and competitive site positioning — delivering a proposal-ready strategy in minutes, not days.
→ Country strategy finalisedDeep Intelligence Layer
Plume™ enriches your strategy with 50+ curated datasets — epidemiology mapping, site outreach data, startup timelines, and competitive benchmarking at global scale.
→ Intelligence package completeRisk Modelling & Simulation
Simulator-L™ runs AI-powered projections of enrolment performance and timeline scenarios — quantifying execution risk before a single dollar of capital is committed.
→ Risk-adjusted proposal deliveredGet Started
Ready to Transform Your Workflow?
Join leading CROs using Aurora Analytica™ to compress 10-day RFP cycles into data-driven proposals delivered in hours.
Built by People Who Know Clinical Trials
Three decades of CRO experience, deep technical expertise, and a shared obsession with making clinical trial strategy smarter.
Ola Gudmundsen
Chairman30+ years in clinical research and CRO leadership. As Founder of LINK Medical Research, Ola brings unmatched expertise in trial operations, sponsor relationships, and CRO commercialisation — the strategic foundation that makes Aurora's vision possible.
View on LinkedIn
Bhavish Lekh
CEOFounder and architect of Aurora's decision intelligence platform. 10+ years leading CRO feasibility, analytics, and data-driven strategy — the expertise that shaped every module of the Aurora Suite™ from first principles.
View on LinkedIn
Espen Gudmundsen
CTO10+ years building secure, AI-driven software systems in regulated industries. Architect of scalable distributed platforms and intelligent automation frameworks — the technical force behind Aurora's enterprise-grade infrastructure.
View on LinkedInLatest from Aurora Analytica
Case studies, publications, and company milestones from the team building the future of clinical trial strategy.
More Articles
The Story Behind Aurora Analytica
After a decade leading feasibility operations across 400+ clinical studies, Co-founder & CEO Bhavish Lekh shares the journey from idea to platform — and what's next for Aurora Analytica.
Read Article →Aurora Analytica Welcomes Espen Gudmundsen as CTO
Espen Gudmundsen joins Aurora Analytica as Chief Technology Officer, bringing 10+ years of expertise in software development, AI, and cybersecurity.
Read Article →Aurora Analytica Awarded 1.2 Million NOK in Innovation Grants from Innovation Norway
Aurora Analytica™ has received a total of 1.2 million NOK in grants from Innovation Norway since 2024, accelerating development of the Aurora Suite™.
Read Article →Breaking Down Silos: A User-Defined Approach to Global Feasibility
How Aurora Analytica™ transforms fragmented data into connected, actionable clinical trial intelligence — going beyond siloed databases.
Read Article →Decision Engines™ vs Data Tools: Navigating Clinical Trials Smarter
Why a GPS beats hundreds of paper maps — exploring the difference between traditional data tools and Aurora's Decision Engines™.
Read Article →Aurora Analytica Recognized by the EIC for Its Ground-breaking Innovation
The European Innovation Council described the Aurora Suite as "a superior solution compared to existing fragmented systems" and a "highly novel, deep tech breakthrough."
Read Article →Aurora Analytica Awarded Innovation Norway Start-up 2 Grant
Aurora Analytica has been awarded the prestigious Start-up 2 grant from Innovation Norway, validating our technology and mission.
Read Article →Delivering New Clinical Trial Wins for CROs
We supported a mid-size CRO through a full feasibility and strategy process, resulting in a won global clinical trial and an NPS of 9.1.
Read Article →Optimizing Phase III Trials in Pancreatic Cancer – ESMO Poster 2024
Our ESMO 2024 poster showcases how the Aurora Suite™ optimizes Phase III trial strategy in pancreatic cancer — delivering 200%+ enrolment improvement and 80%+ time savings.
Read Article →The Story Behind Aurora Analytica
After a decade leading feasibility operations across 400+ clinical studies, Co-founder & CEO Bhavish Lekh shares the journey from idea to platform — and what's next for Aurora Analytica.
Read Article →Aurora Analytica Welcomes Espen Gudmundsen as CTO
Espen Gudmundsen joins Aurora Analytica as Chief Technology Officer, bringing 10+ years of expertise in software development, AI, and cybersecurity.
Read Article →Aurora Analytica Awarded 1.2 Million NOK in Innovation Grants from Innovation Norway
Aurora Analytica™ has received a total of 1.2 million NOK in grants from Innovation Norway since 2024, accelerating development of the Aurora Suite™.
Read Article →Breaking Down Silos: A User-Defined Approach to Global Feasibility
How Aurora Analytica™ transforms fragmented data into connected, actionable clinical trial intelligence — going beyond siloed databases.
Read Article →Decision Engines™ vs Data Tools: Navigating Clinical Trials Smarter
Why a GPS beats hundreds of paper maps — exploring the difference between traditional data tools and Aurora's Decision Engines™.
Read Article →Aurora Analytica Recognized by the EIC for Its Ground-breaking Innovation
The European Innovation Council described the Aurora Suite as "a superior solution compared to existing fragmented systems" and a "highly novel, deep tech breakthrough."
Read Article →Aurora Analytica Awarded Innovation Norway Start-up 2 Grant
Aurora Analytica has been awarded the prestigious Start-up 2 grant from Innovation Norway, validating our technology and mission.
Read Article →Delivering New Clinical Trial Wins for CROs
We supported a mid-size CRO through a full feasibility and strategy process, resulting in a won global clinical trial and an NPS of 9.1.
Read Article →Optimizing Phase III Trials in Pancreatic Cancer – ESMO Poster 2024
Our ESMO 2024 poster showcases how the Aurora Suite™ optimizes Phase III trial strategy in pancreatic cancer — delivering 200%+ enrolment improvement and 80%+ time savings.
Read Article →Get In Touch
Let's talk about your clinical trial strategy
Whether you're a CRO looking to modernise feasibility workflows or a pharma sponsor seeking smarter site selection — we're here to help.
info@aurora-analytica.com
Location
Oslo, Norway
EIC Accelerator
Stage 1 Selected
ESMO Published
Leading Oncology Conference
10/10 NPS
Global CRO Case Study